Inovio Pharmaceuticals
INO
#9182
Rank
HK$0.87 B
Marketcap
HK$12.73
Share price
1.24%
Change (1 day)
-17.94%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -HK$0.85 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are HK$0.18 Million. In 2024 the company made an earning of -HK$0.84 Billion, an increase over its 2023 earnings that were of -HK$1.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.85 Billion0.74%
2024 -HK$0.84 Billion-20.03%
2023 -HK$1.05 Billion-51.56%
2022 -HK$2.16 Billion-8.26%
2021 -HK$2.36 Billion95.4%
2020 -HK$1.21 Billion36.62%
2019 -HK$0.89 Billion20.19%
2018 -HK$0.74 Billion10.94%
2017 -HK$0.67 Billion9.59%
2016 -HK$0.61 Billion118.9%
2015 -HK$0.28 Billion-10.67%
2014 -HK$0.31 Billion83.32%
2013 -HK$0.17 Billion
2011 -HK$0.18 Billion15.64%
2010 -HK$0.16 Billion37.7%
2009 -HK$0.11 Billion2.19%
2008 -HK$0.11 Billion-14.09%
2007 -HK$0.13 Billion19.12%
2006 -HK$0.11 Billion9.62%
2005 -HK$95.08 Million5.77%
2004 -HK$89.9 Million73.08%
2003 -HK$51.94 Million12.75%
2002 -HK$46.07 Million
2000 -HK$69.72 Million53.93%
1999 -HK$45.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$252.99 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$128.22 B-15,289.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$92.55 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$77.20 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$180.31 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$72.80 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-HK$21.5 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$1.10 B-230.35%๐Ÿ‡บ๐Ÿ‡ธ USA